# Agilent Acquires Proscia for AI Pathology Expansion

> Agilent buys Proscia for up to $270m to boost AI-powered digital pathology tools.
- Title: Agilent Acquires Proscia for AI Pathology Expansion | Shortify
- Summary: Agilent buys Proscia for up to $270m to boost AI-powered digital pathology tools. Agilent will acquire Proscia for up to $270 million to expand its…
- Keywords: agilent, proscia, digital pathology, pathology market, companion diagnostics, biopharmaceutical, startups, business, Acquires, Pathology, Expansion, Pulse 2.0
- Source: Pulse 2.0 — https://pulse2.com/agilent-to-acquire-proscia
- Author: Amit Chowdhry
- Published: 2026-10-15T20:47:49+00:00
- Read time: 1 min
- Topics: agilent, proscia, ai, digital pathology, pathology market, companion diagnostics, biopharmaceutical, startups, business
## Agilent Acquires Proscia
Agilent Technologies agreed to acquire Proscia, a digital pathology software provider, in an all-cash transaction valued at $240 million plus up to $30 million in performance milestones.
## Digital Pathology Expansion
The acquisition combines Agilent’s instruments and reagents with Proscia’s software to strengthen its position in the $5 billion pathology market.
## Proscia's Platform
Proscia’s software connects slide scanners, lab systems, ai tools, people, and data into a unified digital pathology environment.
## Market Reach
Proscia serves over 4,000 labs, hospitals, clinics, and 16 of the world’s 20 largest pharmaceutical companies.
## FDA Clearance
Proscia’s platform has received FDA 510(k) clearance for primary diagnosis, enabling ai-driven pathology workflows.
## Next Steps
The acquisition will close early in Agilent’s fiscal 2027, integrating Proscia into its Life Sciences and Diagnostics Markets Group.
## Key takeaway

Agilent will acquire Proscia for up to $270 million to expand its AI-enabled digital pathology platform.